1-7 of 7
Keywords: hepatocellular carcinoma
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles
Biochem J (2023) 480 (24): 2045–2058.
Published: 18 December 2023
... selective overexpression in multiple cancers and its role in preventing ferroptosis. Utilizing pharmacological and genetic approaches in hepatocellular carcinoma cell lines, we demonstrate that overexpression of SLC7A11 engenders hypersensitivity towards l -selenocystine, a naturally occurring diselenide...
Includes: Supplementary data
Articles
Biochem J (2022) 479 (19): 2115–2130.
Published: 14 October 2022
... liver disease. Importantly, we demonstrate a tumour suppressor role for Claspin. Reduced Claspin levels result in increased liver damage and tumourigenesis in the DEN model of hepatocellular carcinoma. These data reveal that Clspn haploinsufficiency has widespread unanticipated biological effects...
Includes: Supplementary data
Articles
Biochem J (2022) 479 (12): 1361–1374.
Published: 24 June 2022
... factors hepatocellular carcinoma hepatocytes liver mathematical modelling Cell-to-cell communication is known since the mid-1800, when Claude Bernard developed the concept of le milieu intérieur , addressing the concept of molecule secretion and action on a distant organ [ 1 , 2 ]. Since...
Articles
Biochem J (2019) 476 (24): 3805–3816.
Published: 23 December 2019
...), in a humidified atmosphere containing 5% CO 2 at 37°C. The cells were split when they reach 70–80% confluence. hepatocellular carcinoma leukaemia toxicology Bacillus thuringiensis synthesises crystalline parasporal inclusions during sporulation and this salient feature makes...
Articles
Biochem J (2011) 438 (2): 349–358.
Published: 12 August 2011
...Zi-Miao Liu; Joseph T. Tseng; Duang-Yang Hong; Huei-Sheng Huang HCC (hepatocellular carcinoma) is among the most common and lethal cancers worldwide with a poor prognosis mainly due to a high recurrence rate and chemotherapy resistance. ATO (arsenic trioxide) is a multi-target drug that has been...
Articles
Biochem J (2009) 417 (3): 717–726.
Published: 16 January 2009
...Ana Paula Pereira Da Silva; Tatiana El-Bacha; Nattascha Kyaw; Reinaldo Sousa Dos Santos; Wagner Seixas Da-Silva; Fabio C. L. Almeida; Andrea T. Da Poian; Antonio Galina 3-BrPA (3-bromopyruvate) is an alkylating agent with anti-tumoral activity on hepatocellular carcinoma. This compound inhibits...
Articles
Biochem J (2008) 411 (2): 379–386.
Published: 27 March 2008
... widely distributed throughout the body. HGF (hepatocyte growth factor) is a pleiotropic cytokine/growth factor involved in the progression of hepatocellular carcinoma. In the present paper, we report the stimulatory effect of HGF on human 5α-R1 transcription in hepatocellular carcinoma cells. Pre...